Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Active not recruiting 3Recruiting 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 84Ovarian Neoplasms 35Breast Neoplasms 32Lung Neoplasms 28Uterine Cervical Neoplasms 18Triple Negative Breast Neoplasms 15Fallopian Tube Neoplasms 15Carcinoma, Ovarian Epithelial 15Small Cell Lung Carcinoma 13Squamous Cell Carcinoma of Head and Neck 10Neuroblastoma 10Esophageal Neoplasms 10Esophageal Squamous Cell Carcinoma 8Central Nervous System Neoplasms 8Recurrence 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Retinoblastoma 5Neoplasm Metastasis 5Brain Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 4Melanoma 4Carcinoma, Squamous Cell 4Testicular Neoplasms 3Oligodendroglioma 3Medulloblastoma 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Glioblastoma 3

Interventions

Cisplatin 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2Paclitaxel 2temoporfin 1pyrotinib 1fluoromisonidazole 1bicalutamide 1Rubidium-82 1Ritonavir 1Radiotherapy, Conformal 1Nivolumab 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Leuprolide 1Ipilimumab 1Indinavir 1Gemcitabine 1Fluorodeoxyglucose F18 1Enzyme-Linked Immunosorbent Assay 1Docetaxel 1Chemotherapy, Adjuvant 1Carboplatin 1CTLA-4 Antigen 1Brachytherapy 1Amifostine 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Salivary Gland Neoplasms × Carboplatin × Clear all
NCT00022217 2013-12-18

Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡